Trial Details

COMPLETED
Basic Information
Clinical ID c6
Identifier NCT07472309
Trial Title Effectiveness and Safety of Upadacitinib for Acute Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis (UC)|Acute Severe Ulcerative Colitis|Upadacitinib
Interventions DRUG: Upadacitinib
Participant Information
Sponsor Xijing Hospital of Digestive Diseases
City Shaanxi
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2023-06-06
Primary Completion Date 2026-03-03
Completion Date 2026-03-03